Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Kidney Disease (CKD) Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 ACE Inhibitors
1.2.3 Calcium Channel Blockers
1.2.4 Beta Blockers
1.2.5 Others
1.3 Market by Application
1.3.1 Global Chronic Kidney Disease (CKD) Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Kidney Disease (CKD) Market Perspective (2018-2033)
2.2 Chronic Kidney Disease (CKD) Growth Trends by Region
2.2.1 Global Chronic Kidney Disease (CKD) Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Chronic Kidney Disease (CKD) Historic Market Size by Region (2018-2023)
2.2.3 Chronic Kidney Disease (CKD) Forecasted Market Size by Region (2024-2033)
2.3 Chronic Kidney Disease (CKD) Market Dynamics
2.3.1 Chronic Kidney Disease (CKD) Industry Trends
2.3.2 Chronic Kidney Disease (CKD) Market Drivers
2.3.3 Chronic Kidney Disease (CKD) Market Challenges
2.3.4 Chronic Kidney Disease (CKD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Kidney Disease (CKD) Players by Revenue
3.1.1 Global Top Chronic Kidney Disease (CKD) Players by Revenue (2018-2023)
3.1.2 Global Chronic Kidney Disease (CKD) Revenue Market Share by Players (2018-2023)
3.2 Global Chronic Kidney Disease (CKD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chronic Kidney Disease (CKD) Revenue
3.4 Global Chronic Kidney Disease (CKD) Market Concentration Ratio
3.4.1 Global Chronic Kidney Disease (CKD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Kidney Disease (CKD) Revenue in 2022
3.5 Chronic Kidney Disease (CKD) Key Players Head office and Area Served
3.6 Key Players Chronic Kidney Disease (CKD) Product Solution and Service
3.7 Date of Enter into Chronic Kidney Disease (CKD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Kidney Disease (CKD) Breakdown Data by Type
4.1 Global Chronic Kidney Disease (CKD) Historic Market Size by Type (2018-2023)
4.2 Global Chronic Kidney Disease (CKD) Forecasted Market Size by Type (2024-2033)
5 Chronic Kidney Disease (CKD) Breakdown Data by Application
5.1 Global Chronic Kidney Disease (CKD) Historic Market Size by Application (2018-2023)
5.2 Global Chronic Kidney Disease (CKD) Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Chronic Kidney Disease (CKD) Market Size (2018-2033)
6.2 North America Chronic Kidney Disease (CKD) Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Chronic Kidney Disease (CKD) Market Size by Country (2018-2023)
6.4 North America Chronic Kidney Disease (CKD) Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Kidney Disease (CKD) Market Size (2018-2033)
7.2 Europe Chronic Kidney Disease (CKD) Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Chronic Kidney Disease (CKD) Market Size by Country (2018-2023)
7.4 Europe Chronic Kidney Disease (CKD) Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Kidney Disease (CKD) Market Size (2018-2033)
8.2 Asia-Pacific Chronic Kidney Disease (CKD) Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Region (2018-2023)
8.4 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chronic Kidney Disease (CKD) Market Size (2018-2033)
9.2 Latin America Chronic Kidney Disease (CKD) Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Chronic Kidney Disease (CKD) Market Size by Country (2018-2023)
9.4 Latin America Chronic Kidney Disease (CKD) Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Kidney Disease (CKD) Market Size (2018-2033)
10.2 Middle East & Africa Chronic Kidney Disease (CKD) Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Country (2018-2023)
10.4 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Chronic Kidney Disease (CKD) Introduction
11.1.4 AbbVie Revenue in Chronic Kidney Disease (CKD) Business (2018-2023)
11.1.5 AbbVie Recent Development
11.2 Allergan
11.2.1 Allergan Company Detail
11.2.2 Allergan Business Overview
11.2.3 Allergan Chronic Kidney Disease (CKD) Introduction
11.2.4 Allergan Revenue in Chronic Kidney Disease (CKD) Business (2018-2023)
11.2.5 Allergan Recent Development
11.3 Amgen
11.3.1 Amgen Company Detail
11.3.2 Amgen Business Overview
11.3.3 Amgen Chronic Kidney Disease (CKD) Introduction
11.3.4 Amgen Revenue in Chronic Kidney Disease (CKD) Business (2018-2023)
11.3.5 Amgen Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Detail
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Chronic Kidney Disease (CKD) Introduction
11.4.4 AstraZeneca Revenue in Chronic Kidney Disease (CKD) Business (2018-2023)
11.4.5 AstraZeneca Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Chronic Kidney Disease (CKD) Introduction
11.5.4 Roche Revenue in Chronic Kidney Disease (CKD) Business (2018-2023)
11.5.5 Roche Recent Development
11.6 FibroGen
11.6.1 FibroGen Company Detail
11.6.2 FibroGen Business Overview
11.6.3 FibroGen Chronic Kidney Disease (CKD) Introduction
11.6.4 FibroGen Revenue in Chronic Kidney Disease (CKD) Business (2018-2023)
11.6.5 FibroGen Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Chronic Kidney Disease (CKD) Introduction
11.7.4 GlaxoSmithKline Revenue in Chronic Kidney Disease (CKD) Business (2018-2023)
11.7.5 GlaxoSmithKline Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Detail
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Chronic Kidney Disease (CKD) Introduction
11.8.4 Johnson & Johnson Revenue in Chronic Kidney Disease (CKD) Business (2018-2023)
11.8.5 Johnson & Johnson Recent Development
11.9 Keryx
11.9.1 Keryx Company Detail
11.9.2 Keryx Business Overview
11.9.3 Keryx Chronic Kidney Disease (CKD) Introduction
11.9.4 Keryx Revenue in Chronic Kidney Disease (CKD) Business (2018-2023)
11.9.5 Keryx Recent Development
11.10 Kissei
11.10.1 Kissei Company Detail
11.10.2 Kissei Business Overview
11.10.3 Kissei Chronic Kidney Disease (CKD) Introduction
11.10.4 Kissei Revenue in Chronic Kidney Disease (CKD) Business (2018-2023)
11.10.5 Kissei Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Detail
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Chronic Kidney Disease (CKD) Introduction
11.11.4 Pfizer Revenue in Chronic Kidney Disease (CKD) Business (2018-2023)
11.11.5 Pfizer Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Detail
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Chronic Kidney Disease (CKD) Introduction
11.12.4 Sanofi Revenue in Chronic Kidney Disease (CKD) Business (2018-2023)
11.12.5 Sanofi Recent Development
11.13 Teva
11.13.1 Teva Company Detail
11.13.2 Teva Business Overview
11.13.3 Teva Chronic Kidney Disease (CKD) Introduction
11.13.4 Teva Revenue in Chronic Kidney Disease (CKD) Business (2018-2023)
11.13.5 Teva Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Chronic Kidney Disease (CKD) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of ACE Inhibitors
Table 3. Key Players of Calcium Channel Blockers
Table 4. Key Players of Beta Blockers
Table 5. Key Players of Others
Table 6. Global Chronic Kidney Disease (CKD) Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Chronic Kidney Disease (CKD) Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Chronic Kidney Disease (CKD) Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Chronic Kidney Disease (CKD) Market Share by Region (2018-2023)
Table 10. Global Chronic Kidney Disease (CKD) Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Chronic Kidney Disease (CKD) Market Share by Region (2024-2033)
Table 12. Chronic Kidney Disease (CKD) Market Trends
Table 13. Chronic Kidney Disease (CKD) Market Drivers
Table 14. Chronic Kidney Disease (CKD) Market Challenges
Table 15. Chronic Kidney Disease (CKD) Market Restraints
Table 16. Global Chronic Kidney Disease (CKD) Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Chronic Kidney Disease (CKD) Market Share by Players (2018-2023)
Table 18. Global Top Chronic Kidney Disease (CKD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Kidney Disease (CKD) as of 2022)
Table 19. Ranking of Global Top Chronic Kidney Disease (CKD) Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Chronic Kidney Disease (CKD) Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Chronic Kidney Disease (CKD) Product Solution and Service
Table 23. Date of Enter into Chronic Kidney Disease (CKD) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Chronic Kidney Disease (CKD) Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Chronic Kidney Disease (CKD) Revenue Market Share by Type (2018-2023)
Table 27. Global Chronic Kidney Disease (CKD) Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Chronic Kidney Disease (CKD) Revenue Market Share by Type (2024-2033)
Table 29. Global Chronic Kidney Disease (CKD) Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Chronic Kidney Disease (CKD) Revenue Market Share by Application (2018-2023)
Table 31. Global Chronic Kidney Disease (CKD) Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Chronic Kidney Disease (CKD) Revenue Market Share by Application (2024-2033)
Table 33. North America Chronic Kidney Disease (CKD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Chronic Kidney Disease (CKD) Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Chronic Kidney Disease (CKD) Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Chronic Kidney Disease (CKD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Chronic Kidney Disease (CKD) Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Chronic Kidney Disease (CKD) Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Chronic Kidney Disease (CKD) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Chronic Kidney Disease (CKD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Chronic Kidney Disease (CKD) Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Chronic Kidney Disease (CKD) Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Chronic Kidney Disease (CKD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Country (2024-2033) & (US$ Million)
Table 48. AbbVie Company Detail
Table 49. AbbVie Business Overview
Table 50. AbbVie Chronic Kidney Disease (CKD) Product
Table 51. AbbVie Revenue in Chronic Kidney Disease (CKD) Business (2018-2023) & (US$ Million)
Table 52. AbbVie Recent Development
Table 53. Allergan Company Detail
Table 54. Allergan Business Overview
Table 55. Allergan Chronic Kidney Disease (CKD) Product
Table 56. Allergan Revenue in Chronic Kidney Disease (CKD) Business (2018-2023) & (US$ Million)
Table 57. Allergan Recent Development
Table 58. Amgen Company Detail
Table 59. Amgen Business Overview
Table 60. Amgen Chronic Kidney Disease (CKD) Product
Table 61. Amgen Revenue in Chronic Kidney Disease (CKD) Business (2018-2023) & (US$ Million)
Table 62. Amgen Recent Development
Table 63. AstraZeneca Company Detail
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca Chronic Kidney Disease (CKD) Product
Table 66. AstraZeneca Revenue in Chronic Kidney Disease (CKD) Business (2018-2023) & (US$ Million)
Table 67. AstraZeneca Recent Development
Table 68. Roche Company Detail
Table 69. Roche Business Overview
Table 70. Roche Chronic Kidney Disease (CKD) Product
Table 71. Roche Revenue in Chronic Kidney Disease (CKD) Business (2018-2023) & (US$ Million)
Table 72. Roche Recent Development
Table 73. FibroGen Company Detail
Table 74. FibroGen Business Overview
Table 75. FibroGen Chronic Kidney Disease (CKD) Product
Table 76. FibroGen Revenue in Chronic Kidney Disease (CKD) Business (2018-2023) & (US$ Million)
Table 77. FibroGen Recent Development
Table 78. GlaxoSmithKline Company Detail
Table 79. GlaxoSmithKline Business Overview
Table 80. GlaxoSmithKline Chronic Kidney Disease (CKD) Product
Table 81. GlaxoSmithKline Revenue in Chronic Kidney Disease (CKD) Business (2018-2023) & (US$ Million)
Table 82. GlaxoSmithKline Recent Development
Table 83. Johnson & Johnson Company Detail
Table 84. Johnson & Johnson Business Overview
Table 85. Johnson & Johnson Chronic Kidney Disease (CKD) Product
Table 86. Johnson & Johnson Revenue in Chronic Kidney Disease (CKD) Business (2018-2023) & (US$ Million)
Table 87. Johnson & Johnson Recent Development
Table 88. Keryx Company Detail
Table 89. Keryx Business Overview
Table 90. Keryx Chronic Kidney Disease (CKD) Product
Table 91. Keryx Revenue in Chronic Kidney Disease (CKD) Business (2018-2023) & (US$ Million)
Table 92. Keryx Recent Development
Table 93. Kissei Company Detail
Table 94. Kissei Business Overview
Table 95. Kissei Chronic Kidney Disease (CKD) Product
Table 96. Kissei Revenue in Chronic Kidney Disease (CKD) Business (2018-2023) & (US$ Million)
Table 97. Kissei Recent Development
Table 98. Pfizer Company Detail
Table 99. Pfizer Business Overview
Table 100. Pfizer Chronic Kidney Disease (CKD) Product
Table 101. Pfizer Revenue in Chronic Kidney Disease (CKD) Business (2018-2023) & (US$ Million)
Table 102. Pfizer Recent Development
Table 103. Sanofi Company Detail
Table 104. Sanofi Business Overview
Table 105. Sanofi Chronic Kidney Disease (CKD) Product
Table 106. Sanofi Revenue in Chronic Kidney Disease (CKD) Business (2018-2023) & (US$ Million)
Table 107. Sanofi Recent Development
Table 108. Teva Company Detail
Table 109. Teva Business Overview
Table 110. Teva Chronic Kidney Disease (CKD) Product
Table 111. Teva Revenue in Chronic Kidney Disease (CKD) Business (2018-2023) & (US$ Million)
Table 112. Teva Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Kidney Disease (CKD) Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Chronic Kidney Disease (CKD) Market Share by Type: 2022 VS 2033
Figure 3. ACE Inhibitors Features
Figure 4. Calcium Channel Blockers Features
Figure 5. Beta Blockers Features
Figure 6. Others Features
Figure 7. Global Chronic Kidney Disease (CKD) Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Chronic Kidney Disease (CKD) Market Share by Application: 2022 VS 2033
Figure 9. Hospitals Case Studies
Figure 10. Specialty Clinics Case Studies
Figure 11. Chronic Kidney Disease (CKD) Report Years Considered
Figure 12. Global Chronic Kidney Disease (CKD) Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Chronic Kidney Disease (CKD) Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Chronic Kidney Disease (CKD) Market Share by Region: 2022 VS 2033
Figure 15. Global Chronic Kidney Disease (CKD) Market Share by Players in 2022
Figure 16. Global Top Chronic Kidney Disease (CKD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Kidney Disease (CKD) as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Chronic Kidney Disease (CKD) Revenue in 2022
Figure 18. North America Chronic Kidney Disease (CKD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Chronic Kidney Disease (CKD) Market Share by Country (2018-2033)
Figure 20. United States Chronic Kidney Disease (CKD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Chronic Kidney Disease (CKD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Chronic Kidney Disease (CKD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Chronic Kidney Disease (CKD) Market Share by Country (2018-2033)
Figure 24. Germany Chronic Kidney Disease (CKD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Chronic Kidney Disease (CKD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Chronic Kidney Disease (CKD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Chronic Kidney Disease (CKD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Chronic Kidney Disease (CKD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Chronic Kidney Disease (CKD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Chronic Kidney Disease (CKD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Chronic Kidney Disease (CKD) Market Share by Region (2018-2033)
Figure 32. China Chronic Kidney Disease (CKD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Chronic Kidney Disease (CKD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Chronic Kidney Disease (CKD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Chronic Kidney Disease (CKD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Chronic Kidney Disease (CKD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Chronic Kidney Disease (CKD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Chronic Kidney Disease (CKD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Chronic Kidney Disease (CKD) Market Share by Country (2018-2033)
Figure 40. Mexico Chronic Kidney Disease (CKD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Chronic Kidney Disease (CKD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Chronic Kidney Disease (CKD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Chronic Kidney Disease (CKD) Market Share by Country (2018-2033)
Figure 44. Turkey Chronic Kidney Disease (CKD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Chronic Kidney Disease (CKD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. AbbVie Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2018-2023)
Figure 47. Allergan Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2018-2023)
Figure 48. Amgen Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2018-2023)
Figure 49. AstraZeneca Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2018-2023)
Figure 50. Roche Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2018-2023)
Figure 51. FibroGen Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2018-2023)
Figure 52. GlaxoSmithKline Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2018-2023)
Figure 53. Johnson & Johnson Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2018-2023)
Figure 54. Keryx Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2018-2023)
Figure 55. Kissei Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2018-2023)
Figure 56. Pfizer Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2018-2023)
Figure 57. Sanofi Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2018-2023)
Figure 58. Teva Revenue Growth Rate in Chronic Kidney Disease (CKD) Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed